AnalystsRobert LeBoyerRobert LeBoyer's Stock Forecasts
AnalystsRobert LeBoyer
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#5203 out of 5550 analysts
Average Return
-18.52%
Win Rate
17%3 out of 18
Risk vs Reward
Poor
Good
Robert LeBoyer's 5 best and worst ratings
Robert LeBoyer Analyst Color
Get additional color on Robert LeBoyer's coverage of popular stocks
Robert LeBoyer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Geovax Labs IncGOVX | 3 | Buy | $10.00 | +5,817.16% | Maintains | 2 months ago |
Nanoviricides IncNNVC | 1 | Buy | $6.00 | +351.13% | Initiates Coverage On | 4 months ago |
Unicycive Therapeutics IncUNCY | 2 | Buy | $50.00 | +1,236.90% | Maintains | 4 months ago |
Tonix Pharmaceuticals Holding CorpTNXP | 2 | Buy | $70.00 | N/A | Reiterates | 2 years ago |
Nutriband IncNTRB | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
Cadrenal Therapeutics IncCVKD | 1 | Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Eledon Pharmaceuticals IncELDN | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Maia Biotechnology IncMAIA | 1 | Buy | $14.00 | N/A | Initiates Coverage On | 4 years ago |
Ayala Pharmaceuticals IncAYLA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Axcella Health IncAXLA | 1 | Buy | $150.00 | N/A | Initiates Coverage On | 5 years ago |
Cerenome IncCNSY | 1 | Strong Buy | $3,000.00 | N/A | Initiates Coverage On | 6 years ago |
Benitec Biopharma IncBNTC | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Anavex Life Sciences CorpAVXL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 6 years ago |
Cns Pharmaceuticals IncCNSP | 1 | Strong Buy | $9,900,000.00 | N/A | Initiates Coverage On | 6 years ago |
Vtv Therapeutics IncVTVT | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Neurotrope IncNTRP1 | 2 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.